Oncology PracticehTERT expression predicts RCC survival, tumor aggressivenessDecember 4, 2018Renal Cell CarcinomaGenitourinary Cancer
Oncology PracticeAge-related gene expression may affect responses to RCC therapyDecember 4, 2018Renal Cell CarcinomaImmunotherapyGenitourinary CancerImmuno-oncology
Oncology PracticeClear cell RCC with papillary features is still ccRCCDecember 4, 2018Renal Cell CarcinomaGenitourinary Cancer
Oncology PracticeStereotactic radiotherapy highly effective for brain mets in RCCNovember 30, 2018Renal Cell CarcinomaGenitourinary CancerCNS/Brain Cancer
Oncology PracticeBAP1 expression augurs prognosis of metastatic RCCNovember 19, 2018Renal Cell CarcinomaGenitourinary Cancer
Oncology PracticePD-L1 correlates with worse sporadic, hereditary ccRCC outcomesNovember 19, 2018Renal Cell CarcinomaImmuno-oncologyGenitourinary Cancer
Oncology PracticeRefractory immune-mediated colitis: Fecal transplant may be the answerNovember 12, 2018Immuno-oncologyGenitourinary CancerRenal Cell CarcinomaPatient & Survivor Care
Oncology PracticeSRS beats surgery in early control of brain mets, advantage fades with timeNovember 9, 2018CNS/Brain CancerBreast CancerMelanomaGastroenterologyGenitourinary CancerRenal Cell CarcinomaGastrointestinal Cancer
Oncology PracticeCirculating tumor DNA identified by fragment sizeNovember 7, 2018Gynecologic CancerGenitourinary CancerBreast CancerRenal Cell CarcinomaCNS/Brain CancerMelanoma
Oncology PracticeTumor burden in active surveillance for mRCC may inform treatment decisionsNovember 6, 2018Renal Cell CarcinomaGenitourinary Cancer
Oncology PracticeStriking racial/ethnic differences seen in RCC featuresNovember 5, 2018Renal Cell CarcinomaGenitourinary Cancer
Oncology PracticeKPNA2 is “novel prognostic factor” in RCCNovember 2, 2018Renal Cell CarcinomaGenitourinary Cancer
Oncology PracticeATLAS: High-risk RCC patients might benefit from adjuvant axitinibOctober 31, 2018Renal Cell CarcinomaGenitourinary Cancer
Oncology PracticeCheckpoint inhibitor/TKI combo improves PFS of RCC over sunitinibOctober 22, 2018Renal Cell CarcinomaGenitourinary CancerImmuno-oncology
Oncology PracticemRCC: Pazopanib appears safe in renal failureOctober 16, 2018Renal Cell CarcinomaGenitourinary Cancer
